# A Multicenter Randomized Open-label Study of Oseltamivir Combined With HD-DEX Versus HD-DEX in the Management of ITP

> **NCT01965626** · PHASE2 · COMPLETED · sponsor: **Shandong University** · enrollment: 96 (actual)

## Conditions studied

- Thrombocytopenia

## Interventions

- **DRUG:** Oseltamivir
- **DRUG:** Dexamethasone

## Key facts

- **NCT ID:** NCT01965626
- **Lead sponsor:** Shandong University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2016-02-01
- **Primary completion:** 2018-05
- **Final completion:** 2019-05
- **Target enrollment:** 96 (ACTUAL)
- **Last updated:** 2020-08-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01965626

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01965626, "A Multicenter Randomized Open-label Study of Oseltamivir Combined With HD-DEX Versus HD-DEX in the Management of ITP". Retrieved via AI Analytics 2026-06-01 from https://api.ai-analytics.org/clinical/NCT01965626. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*